 "Intra-day trading calls from Geojit BNP Paribas")
COAL INDIA (Rs 317.60)
Support at Rs 315.20 below Rs 310.55. Resistance is at Rs 320.75 above Rs 324.50. (Sell for intraday with a stoploss above Rs 324.50)
[MACD SELL + VOLUME BUILD UP + BELOW 100 & 200 DMA]
BHEL (Rs 103.70)
Support at Rs 100 below Rs 97. Resistance is at Rs 105.50 above Rs 108. (Sell for intraday with a stoploss above Rs 108)
SUN PHARMA (Rs 870.45)
Support at Rs 865.10 below Rs 862.25. Resistance is at Rs 883 above Rs 886.35. (Buy for intraday with a stoploss below Rs 862.25)
[STOCHASTICS BUY + RISE IN VOLUME + ABV MOVING AVERAGES]
ASHAPURA MINECHEM (Rs 66.50)
Support at Rs 65.10 below Rs 64.25. Resistance is at Rs 67.90 above Rs 68.55. (Buy for intraday with a stoploss below Rs 64.25)
[VOLUME JUMP + ABV PREVIOUS CLOSE + MACD & STOCHASTICS BUY]
SURYA ROSHNI (Rs 136.30)
Support at Rs 133 below Rs 132.60. Resistance is at Rs 140.20 above Rs 142.55 (Buy for intraday with a stoploss below Rs 132.60)
[STOCHASTICS BUY+ VOLUME JUMP + ABV PREVIOUS CLOSE + ABV 200 DMA]
Disclaimer: This report has been prepared by Geojit BNP Paribas Financial Services Limited (GBNPP), here in after referred to as GBNPP. GBNPP, a publicly listed company, is engaged in services of retail broking, credit, portfolio management and marketing investment products including mutual funds, life and general insurance and properties. Each recipient of this report should make such investigation as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this report (including the merits and risks involved). This document is not for public distribution and has been furnished to you solely for your information and must not be reproduced or redistributed to any other person. Persons into whose possession this document may come are required to observe these restrictions. Opinion expressed herein is our current opinion as of the date appearing on this report only. While we endeavor to update on a reasonable basis the information discussed in this material, there may be regulatory, compliance, or other reasons that prevent us from doing so. Prospective investors and others are cautioned that any forward-looking statements are not predictions and may be subject to change without notice.
Support at Rs 315.20 below Rs 310.55. Resistance is at Rs 320.75 above Rs 324.50. (Sell for intraday with a stoploss above Rs 324.50)
[MACD SELL + VOLUME BUILD UP + BELOW 100 & 200 DMA]
BHEL (Rs 103.70)
Support at Rs 100 below Rs 97. Resistance is at Rs 105.50 above Rs 108. (Sell for intraday with a stoploss above Rs 108)
More From This Section
[BELOW MOVING AVERAGES + BELOW PREVIOUS CLOSE + VOLUME JUMP + MACD & STOCHASTICS SELL]
SUN PHARMA (Rs 870.45)
Support at Rs 865.10 below Rs 862.25. Resistance is at Rs 883 above Rs 886.35. (Buy for intraday with a stoploss below Rs 862.25)
[STOCHASTICS BUY + RISE IN VOLUME + ABV MOVING AVERAGES]
ASHAPURA MINECHEM (Rs 66.50)
Support at Rs 65.10 below Rs 64.25. Resistance is at Rs 67.90 above Rs 68.55. (Buy for intraday with a stoploss below Rs 64.25)
[VOLUME JUMP + ABV PREVIOUS CLOSE + MACD & STOCHASTICS BUY]
SURYA ROSHNI (Rs 136.30)
Support at Rs 133 below Rs 132.60. Resistance is at Rs 140.20 above Rs 142.55 (Buy for intraday with a stoploss below Rs 132.60)
[STOCHASTICS BUY+ VOLUME JUMP + ABV PREVIOUS CLOSE + ABV 200 DMA]
Disclaimer: This report has been prepared by Geojit BNP Paribas Financial Services Limited (GBNPP), here in after referred to as GBNPP. GBNPP, a publicly listed company, is engaged in services of retail broking, credit, portfolio management and marketing investment products including mutual funds, life and general insurance and properties. Each recipient of this report should make such investigation as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this report (including the merits and risks involved). This document is not for public distribution and has been furnished to you solely for your information and must not be reproduced or redistributed to any other person. Persons into whose possession this document may come are required to observe these restrictions. Opinion expressed herein is our current opinion as of the date appearing on this report only. While we endeavor to update on a reasonable basis the information discussed in this material, there may be regulatory, compliance, or other reasons that prevent us from doing so. Prospective investors and others are cautioned that any forward-looking statements are not predictions and may be subject to change without notice.